Sickle Cell in Focus 2012

Another successful year! Thank you to everyone involved for contributing to such an engaging and interesting two days.

If you would like to be included on the mailing list, please send an email to Annabelle at: info[@]ststn.co.uk.

Until next year!

KEY INFORMATION:

  • 24-25 May 2012, King’s College London Denmark Hill campus, London SE5 9RJ
  • The programme has now been finalised and can be downloaded here: Sickle Cell in Focus 2012 programme (pdf 425kb)
  • Registration prices vary from £100 – £350
  • SCiF 2012 has received 13 EHA-CME accreditation points

 PROGRAMME:

Thursday 24  May 2012

08:50 – 09:00 Welcome from Michael Parker, President, Sickle Cell Society

  • SESSION 1: SICKLE CELL DISEASE: A GLOBAL PERSPECTIVE

09:00 – 09:30  Keeping patients well: a global view
Kwaku Ohene-Frempong, The Children’s Hospital of Philadelphia, USA

09:30 – 10:00  The many faces of sickle cell disease
Miguel Abboud, American University of Beirut Medical Center, Lebanon

10:00 – 10:30  Transition: a vulnerable time
Marianne De Montalembert, Necker-Enfants Malades Hospital, France

10:30 – 11:00 Mid-morning break (James Black Centre foyer)

 

 

  • SESSION 2: SICKLE CELL: BOTH A QUALITATIVE AND A QUANTITATIVE TRAIT

11:00 – 11:25 HbAS with sickle complications: a diagnostic challenge
Swee Lay Thein, King’s College London / King’s College Hospital, UK

11:25 – 11:50  Sickle cell trait and renal complications
Claire Sharpe, King’s College London / King’s College Hospital, UK

11:50 – 12:15  Limitations of HbF as a phenotype modifier
Adekunle Adekile, Kuwait University, Kuwait

  • SESSION 3: COMPLICATIONS AND MANAGEMENT ISSUES

12:15 – 12:40  Heart and pulmonary vasculature in sickle cell disease
Gerry Coghlan, Royal Free Hospital, UK

12:40 – 14:00 Extended buffet lunch (James Black Centre foyer)

14:00 – 14:30  Stroke prevention: 20 years on
Robert Adams, MUSC Stroke Center, USA

14:30 – 15:00  Extracranial causes of stroke in sickle cell disease
David Rees, King’s College London / King’s College Hospital, UK

15:00 – 15:30  Cognition in sickle cell disease
Fenella Kirkham, UCL Institute of Child Health/ Southampton University Hospital, UK

15:30 – 16:00 Afternoon break (James Black Centre foyer)

  • SESSION 4: COMPLICATIONS AND MANAGEMENT ISSUES

16:00 – 16:30  Managing pregnancy in sickle cell disease
Jo Howard, Guys and St Thomas’ Hospital, UK

16:30 – 17:00  Update on blood transfusion in sickle cell disease
Alek Mijovic, King’s College Hospital, UK

17:00 – 17:30 Sexual dysfunction, fertility issues and priapism in sickle cell disease
Nick Watkin, St. George’s Hospital, UK

17:30                  DAY ONE CLOSE

Friday 25  May 2012

08:50 – 09:00 Welcome from Alan McGregor, Campus Dean, King’s Denmark Hill campus

  •  SESSION 1 COMPLICATIONS AND MANAGEMENT ISSUES

09:00 – 09:30 Case studies: complications in pregnancy
Emma Drasar, King’s College London / King’s College Hospital, UK

09:30 – 10:05  The many faces of sickle cell pain
Samir Ballas, Thomas Jefferson University, USA

10:05 – 10:35 Bone and joint complications
Marcus Bankes, Guys and St Thomas’ Hospital, UK

10:35 – 11:05  Iron overload
John Porter, University College London, UK

11:05 – 11:35  Mid-morning break (James Black Centre foyer)

  • SESSION 2 THE HAEMOLYSIS PARADIGM IN SICKLE CELL DISEASE

11:35 – 12:05  Hemolytic anemia as a mechanism for vasculopathy and pulmonary hypertension in sickle cell disease
Mark Gladwin, University of Pittsburgh Medical Center, USA

12:05 – 12:35  The hyper-hemolysis paradigm from the perspectives of systems biology and evidence based medicine
Robert Hebbel, University of Minnesota, USA

12:35 – 12:55  Discussion

12:55 – 13:55  Buffet lunch (James Black Centre foyer)

  • SESSION 3 EVOLVING CONCEPTS AND EMERGING THERAPIES

13:55 – 14:25  Novel aspects of imaging in sickle cell disease
John Wood, Children’s Hospital Los Angeles, USA

14:25 – 14:55  Inflammation and endothelial cell activation as therapeutic targets in sickle cell disease
Fernando Ferreira Costa, UNICAMP, Brazil

14:55 – 15:25  HbF reactivation: a pipeline for epigenetic and targeted therapeutics
Susan Perrine, Boston University School of Medicine, USA

15:25 – 15:55  Sickle cell disease: lessons learned from clinical trials
Abdullah Kutlar, Medical College of Georgia, USA

15:55 – 16:25   Afternoon break (James Black Centre foyer)

  • SESSION 4 BONE MARROW TRANSPLANT

16:25 – 16:55  Bone marrow transplant in children
Josu de la Fuente, Imperial College London, UK

16:55 – 17:25  Non-myeloablative allogenic heamtopoietic stem cell transplantation (allo-HSCT) for patients with severe sickle cell disease
John Tisdale, National Institute of Health

17:25   CONFERENCE CLOSE

 

 

Comments are closed.